Gracell Biotechnologies Inc. (GRCL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$0.99B
EV to revenue ratio (TTM)
150.04
EV to ebitda
-1.57
Financial Performance
Revenue (TTM)
$0B
Gross profit (TTM)
$0.00B
EBITDA
-$0.51B
Profitability
Operating margin (TTM)
<0.01%
Profit margin
<0.01%
Return on assets (TTM)
-19.40%
Return on equity (TTM)
-31.60%
Per Share Metrics
Revenue per share (TTM)
$0
EPS
-$0.97
Diluted EPS (TTM)
-$0.97
Book value
$16.90
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
n/a
Price to sales ratio (TTM)
732.21
Price to book ratio (TTM)
4.39
Growth
Quarterly earnings growth (YoY)
<0.01%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
n/a
Buy
n/a
Hold
n/a
Sell
n/a
Strong sell
n/a
Risk & Volatility
Beta
-0.35